AwardedSpainGoodsFramework agreement€12,120,208
Suministro sucesivo del medicamento Brexucabtagen Autoleucel
- Published
- Published 30 April 2026
Overview
The Servizo Galego de Saúde has awarded a successive supply contract for Brexucabtagen Autoleucel, an advanced medicinal product, to GILEAD SCIENCES, S.L. on 25 April 2026. This is the second contract awarded under a framework agreement, with an estimated value of approximately 12.1 million EUR.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €12,120,208
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 30 April 2026
Antineoplastic agents
Award outcome
- Awarded value
- €0
- Award date
- 25 April 2026
- Contract period
- — → 14 April 2028
- GILEAD SCIENCES, S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
30 April 2026
Contracting authority
Servizo Galego de Saúde. Área Sanitaria de Vigo
Procuring entityVigo, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.